Optimization of Pediatric Tonsillectomy to IMprove AnaLgesia
Duke University · with National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · NCT06576830
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 3–17 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Phase 4
- Target enrollment
- 440
- US sites recruiting
- 1
- Study start
- November 21, 2024
- Record last updated
- December 5, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this study is to compare the use of short acting opioids (fentanyl/hydromorphone) with long acting opioids (methadone) for pain control following tonsillectomy surgery in children and adolescents.
Being studied: Methadone; Fentanyl/Hydromorphone
Conditions: Pain, Postoperative; Tonsillar Hypertrophy; Tonsillitis; Pediatric Sleep Apnea; Sleep-Disordered Breathing
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Age >= 3 and \< 18 years
- Elective tonsillectomy +/- adenoidectomy
- Signed informed consent by parent or legal guardian
- Children >= 12 years must provide signed written consent, Children >= 7 years must provide verbal assent
- Negative pregnancy test within 48 hours for post pubescent females
Exclusion Criteria
- History of chronic kidney or liver disease
- Current diagnosis of a chronic pain disorder
- Planned admission to the Pediatric Intensive Care Unit (PICU)
- Additional procedures under general anesthesia for which opioids would be prescribed
Recruiting US locations
Duke University Medical Center
Durham, NC 27710
Site contact: Lisa Einhorn · lisa.einhorn@duke.edu
Study contacts (from the official record)
- Lisa M Einhorn, MD · 9196814877 · lisa.einhorn@duke.edu
Similar studies in North Carolina
All sleep studies in North Carolina →- RecruitingPhase 2/Phase 3
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
Alkermes, Inc.
- Location
- Denver, NC + 32 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 2
A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)
Takeda
- Location
- Denver, NC + 24 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 3
A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH
Jazz Pharmaceuticals
- Location
- Denver, NC + 14 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
Alkermes, Inc.
- Location
- Charlotte, NC + 21 other US sites
- Eligibility basics
- Ages 18–70